← Back to Patent Explorer
US4262011A Expired / Lapsed US ⏱️ 0.0 years remaining

1-1-Disubstituted-pen-2-em-3-carboxylic acids

Assignee: Merck and Co Inc
•
Filing: 1979-12-03
•
Granted: 1981-04-14
•
Expires: 1999-12-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 1-substituted-pen-2-em-3-carboxylic acids (I) and their pharmaceutically acceptable salts and esters which are useful as antibiotics; such compounds are prepared by total synthesis. <IMAGE> I wherein R1 and R2 are, inter alia, substituted and unsubstituted alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, and spirocycloalkyl.

Inventors

  • 👤 Burton G. Christensen
  • 👤 David H. Shih

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 06:47
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/10; C07D477/12; C07D477/14; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/568

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 108 words
A compound having the formula: ##STR22## and its pharmaceutically acceptable salts and wherein R 1 and R 2 are selected from the group consisting of substituted and unsubstituted: loweralkyl having from 1-6 carbon atoms, phenyl, phenylloweralkyl, cycloalkyl having from 3 to 6 carbon atoms, cycloalkylalkyl having 1 to 7 carbon atoms in the chain and 3-6 carbon atoms in the ring and spirocycloalkyl having 3-6 carbon atoms; wherein said substituents on R 1 and R 2 are selected from the group consisting of halogen, hydroxyl, amino, and substituted amino, azido, cyano, carboxyl, alkoxyl, and mono-, di- and trialkylamino, each alkyl radical of the foregoing having 1-6 carbon atoms.
Claim 2
Dependent Claim 108 words
A compound having the formula: ##STR22## and its pharmaceutically acceptable salts and wherein R 1 and R 2 are selected from the group consisting of substituted and unsubstituted: loweralkyl having from 1-6 carbon atoms, phenyl, phenylloweralkyl, cycloalkyl having from 3 to 6 carbon atoms, cycloalkylalkyl having 1 to 7 carbon atoms in the chain and 3-6 carbon atoms in the ring and spirocycloalkyl having 3-6 carbon atoms; wherein said substituents on R 1 and R 2 are selected from the group consisting of halogen, hydroxyl, amino, and substituted amino, azido, cyano, carboxyl, alkoxyl, and mono-, di- and trialkylamino, each alkyl radical of the foregoing having 1-6 carbon atoms.
Claim 3
Dependent Claim 23 words
A compound according to claim 1 wherein R 1 and R 2 are selected from methyl, phenyl, ethyl, cyclopropyl, propyl, isopropyl, and spiro-cyclopropyl.
Claim 4
Dependent Claim 10 words
A compound according to claim 1 having the structure: ##STR23##
Claim 5
Dependent Claim 10 words
A compound according to claim 1 having the structure: ##STR24##
Claim 6
Dependent Claim 25 words
An antibiotic pharmaceutical composition comprising a therapeutically effective amount of a compound according to claims 1, 2, 3 or 4 and a pharmaceutical carrier therefor.
Claim 7
Independent Claim 21 words
A method of treatment comprising administering an antibiotically effective amount of a compound according to claims 1, 2, 3, or 4.

References Cited (Backward Citations)

US4181733A Cited
US4206219A Cited
US4208422A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-04-13 1984-10-13 1985-04-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-04-13 1988-10-13 1989-04-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-04-13 1992-10-13 1993-04-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag